Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Jackson

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Arthritis and Rheumatism|October 2, 2007
T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201Nadine L Dudek, Shannon Maier, Zhen-Jun Chen, et al.
The Journal of Biological Chemistry|March 21, 2007
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptidesAbigail Clements, Dedreia Tull, Adam W Jenney, et al.
International Journal of Molecular Sciences|January 21, 2022
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 InfectionBang M Tran, Samantha L Grimley, Julie L McAuley, et al.
JCI Insight|February 9, 2021
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungsGeorgia Deliyannis, Chinn Yi Wong, Hayley A McQuilten, et al.
Plos One|September 9, 2017
Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitudeKylie M Quinn, Wan-Ting Kan, Katherine A Watson, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Journal of Virology|April 15, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses and neutralizing antibody inductionTomomi Kawakita, Toshiki Sekiya, Yayoi Kameda, et al.
Immunology and Cell Biology|August 3, 2020
Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assaysMarios Koutsakos, Toshiki Sekiya, Brendon Y Chua, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Vaccine|June 6, 2021
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cellsMasashi Shingai, Naoki Nomura, Toshiki Sekiya, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Arthritis and Rheumatism|October 2, 2007
T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the HLA class II haplotype DRB1*0301/DQB1*0201Nadine L Dudek, Shannon Maier, Zhen-Jun Chen, et al.
The Journal of Biological Chemistry|March 21, 2007
Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptidesAbigail Clements, Dedreia Tull, Adam W Jenney, et al.
International Journal of Molecular Sciences|January 21, 2022
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 InfectionBang M Tran, Samantha L Grimley, Julie L McAuley, et al.
JCI Insight|February 9, 2021
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungsGeorgia Deliyannis, Chinn Yi Wong, Hayley A McQuilten, et al.
Plos One|September 9, 2017
Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitudeKylie M Quinn, Wan-Ting Kan, Katherine A Watson, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Journal of Virology|April 15, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses and neutralizing antibody inductionTomomi Kawakita, Toshiki Sekiya, Yayoi Kameda, et al.
Immunology and Cell Biology|August 3, 2020
Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assaysMarios Koutsakos, Toshiki Sekiya, Brendon Y Chua, et al.
Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.
Vaccine|June 6, 2021
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cellsMasashi Shingai, Naoki Nomura, Toshiki Sekiya, et al.
Pageof 12